# Deflazacort Oral Suspension

NDC: 57664-993
Generic name: Deflazacort Oral
Labeler / Manufacturer: Sun Pharmaceutical Industries, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20260202

FDA application: ANDA219930

## Active ingredients

- DEFLAZACORT: 22.75 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57664-993"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57664-993
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2fac1332-0247-1047-e063-6294a90a557f